Stock Analysis on Net
Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Paying user area

Try for free

AbbVie Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

AbbVie Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Short-term borrowings
Current portion of long-term debt and finance lease obligations
Sales rebates
Dividends payable
Accounts payable
Current portion of contingent consideration liabilities
Salaries, wages and commissions
Royalty and license arrangements
Other
Accounts payable and accrued liabilities
Current liabilities
Long-term debt and finance lease obligations, excluding current portion
Deferred income taxes
Contingent consideration liabilities
Liabilities for unrecognized tax benefits
Income taxes payable
Pension and other post-employment benefits
Other
Other long-term liabilities
Long-term liabilities
Total liabilities
Common stock, $0.01 par value
Common stock held in treasury, at cost
Additional paid-in-capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Stockholders’ equity
Noncontrolling interest
Total equity
Total liabilities and equity

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Short-term borrowings
Show a declining trend from 0.02% in 2020 to 0% in 2022, with no data available for subsequent years, indicating a reduction or elimination of this liability component in recent periods.
Current portion of long-term debt and finance lease obligations
Fluctuates over the period, initially increasing from 5.62% in 2020 to 8.52% in 2021, then decreasing to 2.98% in 2022 before stabilizing around 5% in 2023 and 2024, suggesting variable short-term repayment obligations.
Sales rebates
Consistently increases from 4.77% in 2020 to 10.58% in 2024, more than doubling over five years, which could point to higher rebate costs or aggressive sales incentive programs.
Dividends payable
Shows a steady increase each year from 1.55% in 2020 to 2.17% in 2024, reflecting rising dividend obligations.
Accounts payable
Increases from 1.51% in 2020 to a peak of 2.74% in 2023, then slightly decreases to 2.18% in 2024, indicating greater short-term operational obligations that slightly eased in the last year.
Current portion of contingent consideration liabilities
Emerges in 2021 at 0.85% and steadily rises to 1.92% in 2024, suggesting increasing near-term obligations related to contingent liabilities.
Salaries, wages and commissions
Generally trends upward from 1.11% in 2020 to 1.47% in 2024, with a dip in 2022, indicating increasing labor-related current liabilities.
Royalty and license arrangements
Remain relatively stable and low, fluctuating between 0.27% and 0.45%, reflecting modest royalty-related liabilities.
Other current liabilities
Increase moderately from 4.12% in 2020 to 4.93% in 2024, showing a gradual rise in miscellaneous current obligations.
Accounts payable and accrued liabilities
Show a significant upward trend from 13.39% in 2020 to 23.63% in 2024, reflecting a strong growth in obligations due within the short term, possibly due to increased business activity or payment deferrals.
Current liabilities
Discussing the aggregate, current liabilities rise substantially from 19.04% in 2020 to 28.67% in 2024, indicating an overall increase in short-term obligations relative to total liabilities and equity.
Long-term debt and finance lease obligations, excluding current portion
Show a declining trend from 51.51% in 2020 to 38.75% in 2023, followed by a rise to 44.64% in 2024, indicating an initial reduction in long-term debt with partial increase thereafter.
Deferred income taxes
Decrease steadily from 2.42% in 2020 to 1.45% in 2023, with a slight increase to 1.91% in 2024, suggesting lower deferred tax liabilities over the period, with some rebound at the end.
Contingent consideration liabilities
Increase consistently from 8.16% in 2020 to 14.11% in 2024, indicating growing obligations contingent on future events.
Liabilities for unrecognized tax benefits
Trend slightly up from 3.77% in 2020 to 4.96% in 2023, then decline to 3.74% in 2024, showing variability in tax-related uncertain liabilities.
Income taxes payable
Decrease steadily from 2.56% in 2020 to 0.93% in 2024, indicating a reduction in short-term income tax liabilities.
Pension and other post-employment benefits
Decline from 2.27% in 2020 to 0.91% in 2024, suggesting demobilization or better funding of post-employment benefit obligations.
Other long-term liabilities
Increase from 18.34% in 2020 to peak at 24.00% in 2023, then decline somewhat to 22.29% in 2024, indicating variation in other long-term obligations.
Long-term liabilities (aggregate)
Decrease overall from 72.27% in 2020 to 64.19% in 2023, then rise to 68.84% in 2024, showing fluctuation but remaining a dominant portion of total liabilities and equity.
Total liabilities
Fluctuate between 91.3% in 2020, drop to 87.55% in 2022, then increase sharply to 97.51% in 2024, indicating rising leverage and growing reliance on liabilities over equity financing.
Common stock
Remain negligible and constant at 0.01% across all years, reflecting minimal impact on capital structure.
Common stock held in treasury
Increase in negative values from -1.5% in 2020 to -6.07% in 2024, indicating a growing amount of stock held in treasury, reducing total equity.
Additional paid-in-capital
Increase steadily from 11.55% in 2020 to 15.78% in 2024, contributing positively to equity.
Retained earnings (accumulated deficit)
Rise initially from 0.7% in 2020 to 3.45% in 2022, followed by a decline into negative territory at -5.84% in 2024, signaling losses or dividend distributions exceeding earnings in recent years.
Accumulated other comprehensive loss
Decrease in absolute value from -2.07% in 2020 to -1.42% in 2024, indicating marginal improvement in accumulated losses from other comprehensive income.
Stockholders’ equity
Increases from 8.68% in 2020 to a peak of 12.43% in 2022 before declining sharply to 2.46% in 2024, reflecting decreasing equity base relative to liabilities.
Noncontrolling interest
Remain negligible and stable around 0.02% - 0.03% throughout the period.
Total equity
Follows a similar pattern to stockholders' equity, increasing to 12.45% in 2022 before falling to 2.49% in 2024, indicating a significant reduction in overall equity proportion.
Total liabilities and equity
Sum totals 100% for each year, confirming the relative proportions remain internally consistent.